EMJ Rheumatology 6.1 2019 – European Medical Journal
EMJ Rheumatology 6.1 explores the highlights from the congress, showcasing a selection of peer-reviewed articles.
EMJ Rheumatology 6.1 explores the highlights from the congress, showcasing a selection of peer-reviewed articles.
Discover how biologic therapies impact infection risks in ankylosing spondylitis (AS) patients. A KOBIO registry study highlights respiratory infections, herpes zoster, and key risk factors…
Are you a passionate healthcare professional with a talent for engaging and inspiring others? EMJ is looking for new hosts to lead our renowned podcast…
Study reveals fibromyalgia impacts nearly 20% of lupus patients, reducing quality of life and calling for improved diagnosis and management strategies.
Patients with late-onset rheumatoid arthritis face poorer physical outcomes and higher risks of death and malignancy, highlighting the need for tailored treatments.
Avacopan treatment for vasculitis patients shows a significant risk of liver injury, especially in older and low-weight individuals, stressing the need for close monitoring.
Learn how reduced-dose steroids affect relapse and progression in ANCA-associated vasculitis patients, especially those on rituximab. Explore real-world findings.
Discover how blood flow restriction (BFR) therapy can enhance knee osteoarthritis recovery by improving pain relief, strength, and mobility. Learn more about BFR’s benefits!
Discover how upper extremity disability evolves in early rheumatoid arthritis. Learn about the impact of pain, grip strength, and joint tenderness on long-term outcomes.
Discover a holistic approach to patient care and the mind-body connection in healing in this weeks episode. Watch now
The two doctors explore novel treatment avenues for rheumatic diseases, and discuss the exciting potential of AI in this podcast episode